logo
episode-header-image
Oct 2023
23m 44s

Evolving Biotechnologies with Olga Troya...

Andreessen Horowitz, a16z Bio + Health
About this episode

Olga Troyanskaya, a professor in the department of computer science at Princeton and Deputy Director for Genomics at the Flatiron Institute's Center for Computational Biology, joins Vijay Pande, founding partner of a16z Bio + Health.

Together, they talked about Olga's background and how she got involved in genomics, as well as how evolving biotechnologies have improved scientists’ ability to see different views of the cell. They also discussed social determinants of health, and how, in the future, studies of genomics and SDoH might pave the way to treatment options.

Up next
Jun 20
Streamlining the Patient Referrals Chain with Trey Holterman
In this episode, Tennr cofounder and CEO Trey Holterman sits down with a16z’s David Haber and Jay Rughani to unpack one of healthcare’s most overlooked pain points: patient referral logistics. When a patient is referred to a specialist and told that the specialist will follow up ... Show More
19m 53s
Jun 10
From Chaos to Clarity in Data with Malinka Walaliyadde
What if one of healthcare’s most complex administrative challenges—revenue cycle management—was reframed as a data science problem? In this episode, Malinka Walaliyadde, cofounder and CEO of AKASA, joins Julie Yoo to unpack how large language models have the potential to transfor ... Show More
23m 23s
May 27
Superaging with Eric Topol
What if we stopped trying to cure disease and started preventing it instead? In this episode, Eric Topol, founder and director of the Scripps Research Translational Institute and a cardiologist, scientist, and author, joins a16z general partner Vijay Pande to unpack the future of ... Show More
42m 42s
Recommended Episodes
Oct 2023
Machines & Genes: The Future of AI in Biology with Dr. George Church
In this episode, vanguard geneticist Dr. George Church recounts his storied career from his early fascination with computers and science to his pioneering work in genomics and synthetic biology. Dr. Church developed innovative DNA sequencing methods that enabled the first sequenc ... Show More
49m 48s
Apr 2022
1955: Quanterix (NASDAQ: QTRX) Biomarker Detection Technology
Kevin Hrusovsky, CEO of Quanterix and the Powering Precision Health Summit founder, joins me on the Tech Talks Daily Podcast. Kevin has more than 25 years of experience leading life sciences and biotechnology companies and believes that accelerating precision medicine is the key ... Show More
35m 59s
Sep 2020
The Biology of Aging: Introducing Bio Eats World (ep 1)
Welcome to the first episode of Bio Eats World, a brand new podcast all about how biology is technology. Bio is breaking out of the lab and clinic and into our daily lives -- on the verge of revolutionizing our world in ways we are only just beginning to imagine.In this episode, ... Show More
28m 1s
Dec 2021
What happens when biology becomes technology? | Christina Agapakis
"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More
11m 28s
Jun 2022
What happens when biology becomes technology? | Christina Agapakis
"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More
11m 28s
Dec 2020
What happens when biology becomes technology? | Christina Agapakis
"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More
11m 10s
Feb 2023
CRISPR & bioethics
In the decade since the genome editing capabilities of CRISPR-Cas9 emerged, research into novel medicines has boomed – but alongside progress comes new ethical considerations. Controversy erupted in 2018, when Chinese scientist He Jiankui created the first babies with edited geno ... Show More
55m 17s
Feb 2007
08 - La biotechnologie dans la société : les grands défis de demain
Cours du 14 février 2007 - 2ème heureCollège de FranceLa biotechnologie va permettre dans l'avenir d'améliorer considérablement le traitement des malades. Elle va permettre d'augmenter l'espérance de vie. Mais cette industrie devra résoudre certains problèmes éthiques comme le cl ... Show More
41m 45s
Oct 2023
"مستقبل العافية" - مع الدكتورة دانا السليمان "The Future of Wellness" - with Dr. Dana Al-Sulaiman
اليوم يلتقي رها بالدكتورة دانا السليمان، امرأة سعودية حازت على جوائز عديدة تعمل على تطوير تقنيات البيوتكنولوجيا من الجيل القادم.دانا هي أستاذة مساعدة في علوم المواد والهندسة الحيوية في جامعة الملك عبد الله للعلوم والتقنية (كاوست)، وهي تعمل على تطوير تقنيات بيوتكنولوجيا يمكنها اكت ... Show More
31m 27s
Apr 2024
From Theory to Therapy: The Evolution of AI in Medicine with Dr. Daphne Koller
In this episode of the AI Grand Rounds podcast, Dr. Daphne Koller charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care. Initially intrigued by the capacity of computers for decision-making based on theoreti ... Show More
1h 4m